Correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’ by Imai et al
Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · e131-e132
DOI: 10.1016/j.ard.2026.04.012 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Preeti Lamba und 1 weiteren Autor:innen. Beteiligte Einrichtung: D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India. Electronic address: preeti.lamba@dpu.edu.in. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India. Electronic address: preeti.lamba@dpu.edu.in.
- D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India.
Zitieren
APA
Lamba, P., & Sharma, D. (2026). Correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’ by Imai et al. Annals of the Rheumatic Diseases, 85(11), e131-e132. https://doi.org/10.1016/j.ard.2026.04.012
Vancouver
Lamba P, Sharma D. Correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’ by Imai et al. Annals of the Rheumatic Diseases. 2026;85(11):e131-e132. doi:10.1016/j.ard.2026.04.012
BibTeX
@article{Lamba2026,
author = {Lamba, Preeti and Sharma, Dharmendra},
title = {Correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’ by Imai et al},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {11},
pages = {e131--e132},
doi = {10.1016/j.ard.2026.04.012}
}
EUVIMED